Cancer Detection & Diagnosis

Dachgarten     10:30 - 12:30         Sherif G. Nour and Gerwin P. Schmidt


Prog #

10:30 276.

Correlation of In Vivo MRS and Ex Vivo HR MAS Metabolic Profiles and Clinical Outcome for Brain Metastases Patients

Torill E. Sjøbakk1, Tone F. Bathen1, Roar Johansen2, Kjell A. Kvistad3, Steinar Lundgren, 23, Ingrid S. Gribbestad2

1Norwegian University of Science and Technology, Trondheim, Norway; 2Norwegian University of  Science and Technology, Trondheim, Norway; 3St. Olavs University Hospital, Trondheim, Norway

10:42 277.

Dynamic Contrast Enhanced (DCE) -MRI and 18Fluoromisonidazole (18F MISO) PET Imaging in Head and Neck Squamous Cell Carcinoma: Initial Evaluation of Perfusion and Hypoxia in Nodal Metastasis

Amita Shukla-Dave1, Nancy Lee1, Heiko Schoder1, Ya Wang1, Sadek Nehmeh1, David G. Pfister1, Hilda Stambuk1, Jason A. Koutcher1

1Memorial Sloan-Kettering Cancer Center, New York, USA

10:54 278.

Multiparametric MR Studies for Monitoring Treatment Response of Human Head and Neck Cancer - not available

Sungheon Kim1, Laurie A. Loevner1, Harry Quon1, Mark Rosen1, Oliver Hsu1, Harish Poptani1

1University of Pennsylvania, Philadelphia, Pennsylvania, USA

11:06 279.

Correlating MRI to the Gold Standard of Pathology in Invasive Breast Cancer

Thomas Yankeelov1, Xia Li1, Fouad Boulos1, E. Brian Welch1, Robert E. Lee1, Bapsi Chakravarthy1, Benoit Dawant1, John C. Gore1

1Vanderbilt University, Nashville, Tennessee, USA

11:18 280.

Deconvolution-Based Dynamic Contrast Enhanced MR Imaging of Breast Tumors: Correlation of Perfusion Parameters with HER-2 Gene Amplification and Hormonal Receptor Status

Smitha Makkat1, Claire Bourgain1, Tadeusz Stadnik1, Rob Luypaert1, Martine Dujardin1, Steven Sourbron1, Johan De Mey1

1Vrije Universiteit Brussel, Brussels, Belgium

11:30 281.

Characterization of Renal Masses with Diffusion-Weighted MR Imaging -- A Preliminary Experience

Jingbo Zhang1, Yousef Mazaheri1, Liang Wang1, Lawrence Schwartz1, Paul Russo1, Nicole Ishill1, Hedvig Hricak1

1Memorial Sloan-Kettering Cancer Center, New York, New York, USA

11:42 282.

Diffusion Weighted Imaging in Stage 1 Cervical Cancer: Potential Value in Differentiating Tumour from Post Biopsy Granulation Tissue Using an Endovaginal Technique

Elizabeth M. Charles-Edwards1, Sonali S. De Silva1, Veronica A. Morgan1, Norman McWhinney2, Mike Katesmark2, Nandita M. deSouza1

1CRUK Clinical Magnetic Resonance Research Group, Sutton, Surrey, UK; 2Epsom and St. Helier NHS Trust, Surrey, UK

11:54 283.

Tumor Detection by Diffusion Weighted MRI and ADC-Mapping – Initial Clinical Experiences in Comparison to PET-CT - not available

Matthias Philipp Lichy1, Philip Aschoff1, Christian Plathow1, Alto Stemmer2, Marion I. Menzel2, Wilhelm Horger2, Berthold Kiefer2, Claus D. Claussen1, Christina Pfannenberg3, Heinz-Peter Schlemmer1

1University of Tübingen, Tübingen, Germany; 2Siemens Medical, Erlangen, Germany; 3University of Tübingen, Germany

12:06 284.

Whole Body Diffusion Weighted Imaging and ADC Mapping for Detecting Metastatic Cancer

Michael A. Jacobs1, 2, Li Pan1, Kasia Macura1, Ihab Kamel1, Antonio C. Wolff1, Vered Stearns1, Bassil Okollie1, Christine Lorentz1, David A. Bluemke1

1Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; 2University of Pittsburgh, Pittsburgh, Pennsylvania, USA

12:18 285.

Whole-Body Diffusion-Weighted Imaging: Usefulness for Assessment of M-Stage in Lung Cancer Patients as Compared with Standard Whole-Body MR Imaging and FDG-PET

Yoshiharu Ohno1, Hisanobu Koyama1, Munenobu Nogami1, Daisuke Takenaka1, Nobukazu Aoyama2, Hideaki Kawamitsu2, Takeshi Yoshikawa1, Kazuro Sugimura1

1Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan; 2Kobe University Hospital, Kobe, Hyogo, Japan